Erratum: Auraptene, a Monoterpene Coumarin, Inhibits LTA-Induced Inflammatory Mediators via Modulating NF-κB/MAPKs Signaling Pathways (Evidence-Based Complementary and Alternative Medicine (2021) 2021 (5319584) DOI: 10.1155/2021/5319584)

Chih Hsuan Hsia; Thanasekaran Jayakumar; Wan Jung Lu; Joen Rong Sheu; Chih Wei Hsia; Periyakali Saravana Bhavan; Manjunath Manubolu; Wei Chieh Huang; Yi Chang

doi:10.1155/2022/9805697

Erratum: Auraptene, a Monoterpene Coumarin, Inhibits LTA-Induced Inflammatory Mediators via Modulating NF-κB/MAPKs Signaling Pathways (Evidence-Based Complementary and Alternative Medicine (2021) 2021 (5319584) DOI: 10.1155/2021/5319584)

Chih Hsuan Hsia, Thanasekaran Jayakumar, Wan Jung Lu, Joen Rong Sheu, Chih Wei Hsia, Periyakali Saravana Bhavan, Manjunath Manubolu, Wei Chieh Huang, Yi Chang

研究成果: 雜誌貢獻 › 評論/辯論 › 同行評審

摘要

In the article titled “Auraptene, a Monoterpene Coumarin, Inhibits LTA-Induced Inflammatory Mediators via Modulating NF-κB/MAPKs Signaling Pathways” [1], the corresponding author’s affiliations were listed incorrectly. 'e correct affiliation list is as shown above.

原文	英語
文章編號	9805697
期刊	Evidence-based Complementary and Alternative Medicine
卷	2022
DOIs	https://doi.org/10.1155/2022/9805697
出版狀態	已發佈 - 2022

ASJC Scopus subject areas

補充和替代醫學

存取文件

10.1155/2022/9805697

其它文件與鏈接

指紋

深入研究「Erratum: Auraptene, a Monoterpene Coumarin, Inhibits LTA-Induced Inflammatory Mediators via Modulating NF-κB/MAPKs Signaling Pathways (Evidence-Based Complementary and Alternative Medicine (2021) 2021 (5319584) DOI: 10.1155/2021/5319584)」主題。共同形成了獨特的指紋。

引用此

Hsia, C. H., Jayakumar, T., Lu, W. J., Sheu, J. R., Hsia, C. W., Bhavan, P. S., Manubolu, M., Huang, W. C., & Chang, Y. (2022). Erratum: Auraptene, a Monoterpene Coumarin, Inhibits LTA-Induced Inflammatory Mediators via Modulating NF-κB/MAPKs Signaling Pathways (Evidence-Based Complementary and Alternative Medicine (2021) 2021 (5319584) DOI: 10.1155/2021/5319584). Evidence-based Complementary and Alternative Medicine, 2022, 文章 9805697. https://doi.org/10.1155/2022/9805697

Erratum: Auraptene, a Monoterpene Coumarin, Inhibits LTA-Induced Inflammatory Mediators via Modulating NF-κB/MAPKs Signaling Pathways (Evidence-Based Complementary and Alternative Medicine (2021) 2021 (5319584) DOI: 10.1155/2021/5319584). / Hsia, Chih Hsuan; Jayakumar, Thanasekaran; Lu, Wan Jung 等.
於: Evidence-based Complementary and Alternative Medicine, 卷 2022, 9805697, 2022.

研究成果: 雜誌貢獻 › 評論/辯論 › 同行評審

Hsia, CH, Jayakumar, T, Lu, WJ , Sheu, JR, Hsia, CW, Bhavan, PS, Manubolu, M, Huang, WC & Chang, Y 2022, 'Erratum: Auraptene, a Monoterpene Coumarin, Inhibits LTA-Induced Inflammatory Mediators via Modulating NF-κB/MAPKs Signaling Pathways (Evidence-Based Complementary and Alternative Medicine (2021) 2021 (5319584) DOI: 10.1155/2021/5319584)', Evidence-based Complementary and Alternative Medicine, 卷 2022, 9805697. https://doi.org/10.1155/2022/9805697

Hsia CH, Jayakumar T, Lu WJ , Sheu JR, Hsia CW, Bhavan PS 等. Erratum: Auraptene, a Monoterpene Coumarin, Inhibits LTA-Induced Inflammatory Mediators via Modulating NF-κB/MAPKs Signaling Pathways (Evidence-Based Complementary and Alternative Medicine (2021) 2021 (5319584) DOI: 10.1155/2021/5319584). Evidence-based Complementary and Alternative Medicine. 2022;2022:9805697. doi: 10.1155/2022/9805697

Hsia, Chih Hsuan ; Jayakumar, Thanasekaran ; Lu, Wan Jung 等. / Erratum : Auraptene, a Monoterpene Coumarin, Inhibits LTA-Induced Inflammatory Mediators via Modulating NF-κB/MAPKs Signaling Pathways (Evidence-Based Complementary and Alternative Medicine (2021) 2021 (5319584) DOI: 10.1155/2021/5319584). 於: Evidence-based Complementary and Alternative Medicine. 2022 ; 卷 2022.

@article{6f0afaa8ff5149509fd717152c7e3161,

title = "Erratum: Auraptene, a Monoterpene Coumarin, Inhibits LTA-Induced Inflammatory Mediators via Modulating NF-κB/MAPKs Signaling Pathways (Evidence-Based Complementary and Alternative Medicine (2021) 2021 (5319584) DOI: 10.1155/2021/5319584)",

abstract = "In the article titled “Auraptene, a Monoterpene Coumarin, Inhibits LTA-Induced Inflammatory Mediators via Modulating NF-κB/MAPKs Signaling Pathways” [1], the corresponding author{\textquoteright}s affiliations were listed incorrectly. 'e correct affiliation list is as shown above.",

author = "Hsia, {Chih Hsuan} and Thanasekaran Jayakumar and Lu, {Wan Jung} and Sheu, {Joen Rong} and Hsia, {Chih Wei} and Bhavan, {Periyakali Saravana} and Manjunath Manubolu and Huang, {Wei Chieh} and Yi Chang",

note = "Publisher Copyright: {\textcopyright} 2022 Chih-Hsuan Hsia et al.",

year = "2022",

doi = "10.1155/2022/9805697",

language = "English",

volume = "2022",

journal = "Evidence-based Complementary and Alternative Medicine",

issn = "1741-427X",

publisher = "Hindawi Publishing Corporation",

}

TY - JOUR

T1 - Erratum

T2 - Auraptene, a Monoterpene Coumarin, Inhibits LTA-Induced Inflammatory Mediators via Modulating NF-κB/MAPKs Signaling Pathways (Evidence-Based Complementary and Alternative Medicine (2021) 2021 (5319584) DOI: 10.1155/2021/5319584)

AU - Hsia, Chih Hsuan

AU - Jayakumar, Thanasekaran

AU - Lu, Wan Jung

AU - Sheu, Joen Rong

AU - Hsia, Chih Wei

AU - Bhavan, Periyakali Saravana

AU - Manubolu, Manjunath

AU - Huang, Wei Chieh

AU - Chang, Yi

PY - 2022

Y1 - 2022

N2 - In the article titled “Auraptene, a Monoterpene Coumarin, Inhibits LTA-Induced Inflammatory Mediators via Modulating NF-κB/MAPKs Signaling Pathways” [1], the corresponding author’s affiliations were listed incorrectly. 'e correct affiliation list is as shown above.

AB - In the article titled “Auraptene, a Monoterpene Coumarin, Inhibits LTA-Induced Inflammatory Mediators via Modulating NF-κB/MAPKs Signaling Pathways” [1], the corresponding author’s affiliations were listed incorrectly. 'e correct affiliation list is as shown above.

UR - http://www.scopus.com/inward/record.url?scp=85126775948&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85126775948&partnerID=8YFLogxK

U2 - 10.1155/2022/9805697

DO - 10.1155/2022/9805697

M3 - Comment/debate

AN - SCOPUS:85126775948

SN - 1741-427X

VL - 2022

JO - Evidence-based Complementary and Alternative Medicine

JF - Evidence-based Complementary and Alternative Medicine

M1 - 9805697

ER -